Aberdeen Multi-Market (NYSE: MMT) director files clean Form 4
Rhea-AI Filing Summary
ABERDEEN MULTI-MARKET INCOME FUND director James W. Kilman filed a beneficial ownership report that lists no common stock or derivative transactions for the reported period. The report also shows no reportable holdings or derivative positions as of the date covered.
Positive
- None.
Negative
- None.
Key Figures
Reported buy transactions: 0
Reported sell transactions: 0
Derivative transactions: 0
+1 more
4 metrics
Reported buy transactions
0
Number of buy transactions by James W. Kilman in this Form 4
Reported sell transactions
0
Number of sell transactions by James W. Kilman in this Form 4
Derivative transactions
0
Count of option or other derivative transactions in this Form 4
Holding entries reported
0
Number of post-transaction holding lines shown in the filing
Key Terms
beneficial ownership, derivative transactions, Rule 10b5-1
3 terms
beneficial ownership regulatory
"Filed as a statement of changes in beneficial ownership by a director"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
derivative transactions financial
"Summary shows 0 derivative transactions for the reporting person"
Derivative transactions are contracts whose value depends on the price or performance of something else—like stocks, bonds, currencies, interest rates or commodities. Think of them as insurance or bets about a future price: investors use them to protect against losses, lock in prices, or try to amplify returns, but they can also magnify losses, create cash demands and expose a firm to the risk that the other party won’t meet its obligation, so they can materially affect a company’s financial stability and volatility.
Rule 10b5-1 regulatory
"The Rule 10b5-1 plan affirmation checkbox is not marked for this report"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does ABERDEEN MULTI-MARKET INCOME FUND (MMT) director James W. Kilman report on this Form 4?
The Form 4 shows that no common stock trades and no derivative transactions were reported by director James W. Kilman for the covered period, and it lists no reportable holdings or derivative positions in the issuer.
Does the latest MMT Form 4 show any insider buying or selling by James W. Kilman?
No. The filing reports 0 buy transactions and 0 sell transactions for director James W. Kilman. It also indicates no derivative transactions, implying no reported changes in his ownership position during the covered period.
Are any derivative securities reported for MMT in James W. Kilman’s Form 4?
No. The summary data lists 0 derivative transactions and no derivative positions for James W. Kilman. There are no option exercises, conversions, or other derivative-related changes disclosed in this filing.
Is the MMT Form 4 for James W. Kilman filed under a Rule 10b5-1 trading plan?
The report’s Rule 10b5-1 checkbox is not affirmatively marked for plan-based trading. Combined with the absence of any reported transactions, the filing does not indicate use of a Rule 10b5-1 trading plan during the covered period.